id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2011-0013-0006,DEA,DEA-2011-0013,Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V,Rule,,2011-12-15T05:00:00Z,2011,12,2011-12-15T05:00:00Z,,2015-11-17T17:16:14Z,2011-32172,0,0,0900006480f83b9e
DEA-2011-0013-0002,DEA,DEA-2011-0013,"DEA Background, Data, and Analysis of Ezogabine - September 2011",Supporting & Related Material,,2011-10-21T04:00:00Z,2011,10,,,2011-10-21T14:43:40Z,,0,0,0900006480f57b8c
DEA-2011-0013-0003,DEA,DEA-2011-0013,"HHS Letter, Analysis, and Recommendation for Ezogabine - January 2011",Supporting & Related Material,,2011-10-21T04:00:00Z,2011,10,,,2011-10-21T14:43:40Z,,0,0,0900006480f57b8e
DEA-2011-0013-0001,DEA,DEA-2011-0013,Schedules of Controlled Substances: Placement of Ezogabine into Schedule V,Proposed Rule,,2011-10-21T04:00:00Z,2011,10,2011-10-21T04:00:00Z,2011-11-22T04:59:59Z,2014-01-17T21:39:30Z,2011-27253,0,0,0900006480f58111